What's new

Orphan designation: Seladelpar Treatment of primary biliary cholangitis, 20/02/2025 Positive

Orphan designation: Seladelpar Treatment of primary biliary cholangitis, 20/02/2025 Positive

Mar 12, 2025 - 17:06
 0
Orphan designation: Seladelpar Treatment of primary biliary cholangitis, 20/02/2025 Positive
Orphan designation: Seladelpar Treatment of primary biliary cholangitis, 20/02/2025 Positive
Read More

Tags:

Previous Article

Orphan designation: pelabresib monohydrate Treatment of myelofibrosis, 17/02/202...

Next Article

Orphan designation: Magrolimab Treatment of myelodysplastic syndromes, 26/06/202...

Related Posts

Q&A clinic on human variations web-based electronic application form (eAF), European Medicines Agency, Amsterdam, the Netherlands, from 14 November 2024, 10:00 (CET) to 14 November 2024, 10:30 (CET)

Q&A clinic on human variations web-based electronic app...

Mar 7, 2025  0

Procurement

Procurement

Feb 9, 2025  0

EMEA-003301-PIP01-22-M01

EMEA-003301-PIP01-22-M01

Feb 17, 2025  0